| 85.27 Delayed Data As of 6:30pm ET |  +0.62 / +0.73%Today’s Change | 70.89 Today|||52-Week Range 87.35 | +11.60% Year-to-Date |
| Previous close | 84.65 |
| Today’s open | 84.53 |
| Day’s range | 84.45 - 85.48 |
| Volume | 7,786,715 |
| Average volume (3 months) | 8,486,078 |
| Market cap | $216.1B |
| Earnings growth (last year) | +165.32% |
| Earnings growth (this year) | +17.62% |
| Earnings growth (next 5 years) | +8.90% |
| Revenue growth (last year) | +6.17% |
| P/E ratio | 23.8 |
| Price/Sales | 4.82 |
| Price/Book | 8.24 |
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | -0.61 | -1.62% |
| NVSNovartis | +0.13 | +0.14% |
| ABBVAbbVie | -1.82 | -2.04% |
| AZNAstraZeneca | -0.66 | -1.38% |
| Next reporting date | February 5, 2020 |
| EPS forecast (this quarter) | $1.16 |
| Annual revenue (last year) | $42.4B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 14.65% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
